Mullen ‘Strikingly Different’ EV Crossover Tour Heads to Texas After Completing a Successful Sold Out Stop in Las Vegas Read more
Enlivex Announces Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Alone and in Combination with a PD1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors Read more